Head and Neck Cancer Therapeutics: Global Markets

Sep 2022| PHM264A| BCC Publishing
Sample Report

Report Highlights

The global market for head and neck cancer therapeutics is estimated to increase from $1.7 billion in 2022 to $2.6 billion by 2027, at a compound annual growth rate (CAGR) of 8.5% from 2022 through 2027.

Report Includes

  • 64 data tables and 17 additional tables
  • A comprehensive overview of the global markets for head and neck cancer therapeutics within the industry
  • Analyses of the global market trends, with historic market revenue data for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation and forecast the actual market size for head and neck cancer therapeutics, and corresponding market share analysis by diagnostic method, treatment type, disease indication, route of administration, therapeutic class, end-user, and region
  • Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on COVID-19 impact on the head and neck cancer therapeutics market
  • Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on new products development, regulatory scenario, and reimbursement and pricing factors
  • In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, and major types of end-user markets
  • Market share analysis of the key market participants in the global pharmaceuticals industry, their research priorities, product portfolios, pipeline products, and company competitive landscape
  • Descriptive company profiles of the leading global players, including AstraZeneca plc, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi S.A., Merck & Co., and Pfizer Inc.

Report Scope

This report aims to provide a comprehensive study of the global market for head and neck cancer therapeutics, both in terms of quantitative and qualitative data, to help businesses develop growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding head and neck cancer therapeutic drugs.

An in-depth analysis of the global head and neck cancer therapeutics market includes historical data and market projections on sales by type of diagnostic method, treatment type, disease indication, route of administration, therapeutic class, and end user. It describes the different types of head and neck cancers (lip and oral cavity cancer, laryngeal cancer, oropharyngeal cancer, salivary gland cancer, nasopharyngeal cancer, and hypopharyngeal cancer) and their current and historical market revenues. This report also categorizes the global head and neck cancer therapeutics market based on the route of administration (injectable and oral).

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares. The report also discusses pipeline analysis and the new regulatory landscape of the drugs marketed.

Analyst Credentials

BCC Publishing Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $1.6 billion
Market size forecast $2.5 billion
Growth rate CAGR of 8.5% from 2022 to 2027
Units considered $ Millions
Segments covered Diagnostic Method, Treatment Type, Disease Indication, Route of Administration, Therapeutic Class, End User
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered United States, Canada, Germany, France, U.K., Spain, Italy, Sweden, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Russia, Japan, China, India, Australia, South Korea, Singapore, New Zealand, Taiwan, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa
Key Market Drivers
  • Immunotherapy against Autoimmune Disorders
  • Rising Incidence of Cancer Worldwide
  • Advances in Biochemistry and Genomics
  • High Unmet Need
Companies studied

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesPrice Member Price
Full Report: Head and Neck Cancer Therapeutics: Global Markets148 $5,500 Free
Chapter- 1: Introduction9Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background13$483Free
Chapter- 4: Regulatory Structure5$186Free
Chapter- 5: Market Breakdown, by Diagnostic Method16$595Free
Chapter- 6: Market Breakdown, by Treatment Type20$743Free
Chapter- 7: Market Breakdown, by Disease Indication21$780Free
Chapter- 8: Market Breakdown, by Route of Administration9$334Free
Chapter- 9: Market Breakdown, by Therapeutic Class11$409Free
Chapter- 10: Market Breakdown, by End User14$520Free
Chapter- 11: Market Dynamics4$149Free
Chapter- 12: Impact of COVID-19 on the Market1$37Free
Chapter- 13: Pipeline Analysis1$37Free
Chapter- 14: Competitive Landscape1$37Free
Chapter- 15: Company Profiles20$743Free
Head and Neck Cancer Therapeutics: Global Markets

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries

Need a custom data table, graph or complete report? Tell us more.